US 10611851
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
granted A61PA61P31/04
Quick answer
US patent 10611851 (Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins) held by The Regents of the University of California expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61P, A61P31/04